<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of the 123 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0267406" disease_type="Disease or Syndrome" abbrv="">mesenteric infarction</z:e> treated over the past 12 years, 16 (13%) had mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Eight of the patients with mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> survived the initial episode; two have since died </plain></SENT>
<SENT sid="2" pm="."><plain>The remaining six patients were studied for evidence of haemostatic deficiencies or abnormalities </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001976'>Antithrombin III deficiency</z:hpo>, which is known to be associated with <z:hpo ids='HP_0004850'>recurrent venous thrombosis</z:hpo>, was found in three patients </plain></SENT>
<SENT sid="4" pm="."><plain>It is recommended that <z:hpo ids='HP_0000001'>all</z:hpo> patients with mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> should be screened for <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> as treatment with <z:chebi fb="2" ids="28794">coumarin</z:chebi> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> may be indicated, providing effective prophylaxis against further thrombotic episodes </plain></SENT>
</text></document>